Answers are grounded in this paper and cite their sources.
Reports on oral fosfomycin safety and efficacy in children with urinary tract infections, highlighting an alternative treatment option.
FOSUTI [1] is a pragmatic, multicentre, adaptive, non-inferiority trial to evaluate the safety, tolerability, efficacy and pharmacokinetics of oral fosfomycin to treat children with urinary tract infections (UTIs).
No takes yet. Share an insight, caveat, or question.
Williams et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: